We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.7B
AUM Growth
-$178M
Cap. Flow
-$1.14B
Cap. Flow %
-8.27%
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 26.03%
2 Healthcare 12.56%
3 Financials 11.14%
4 Consumer Discretionary 11.02%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITIC
2676
Investors Title Co
ITIC
$529M
$101K ﹤0.01%
690
CELC icon
2677
Celcuity
CELC
$4.39B
$101K ﹤0.01%
+9,174
New +$95.3K
INZY
2678
DELISTED
Inozyme Pharma
INZY
$100K ﹤0.01%
+18,035
New +$107K
GFS icon
2679
GlobalFoundries
GFS
$29.1B
$100K ﹤0.01%
1,553
-371
-19% -$22.5K
METC icon
2680
Ramaco Resources Class A
METC
$663M
$100K ﹤0.01%
12,268
IBEX icon
2681
IBEX
IBEX
$473M
$99.9K ﹤0.01%
4,706
HUMA icon
2682
Humacyte
HUMA
$165M
$99.9K ﹤0.01%
34,928
LSXMK
2683
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$99.5K ﹤0.01%
3,926
-2,426
-38% -$54.3K
KLTR icon
2684
Kaltura
KLTR
$243M
$99.3K ﹤0.01%
+46,840
New +$87K
STHO icon
2685
Star Holdings Shares of Beneficial Interest
STHO
$118M
$99.2K ﹤0.01%
6,759
NSTG
2686
DELISTED
NanoString Technologies, Inc.
NSTG
$99.1K ﹤0.01%
24,478
TAST
2687
DELISTED
Carrols Restaurant Group, Inc.
TAST
$98.9K ﹤0.01%
+19,629
New +$88.9K
ATOM icon
2688
Atomera
ATOM
$216M
$98.9K ﹤0.01%
11,274
III icon
2689
Information Services Group
III
$242M
$98.9K ﹤0.01%
18,446
+7,729
+72% +$40K
LXRX icon
2690
Lexicon Pharmaceuticals
LXRX
$1.06B
$98.1K ﹤0.01%
42,834
DLB icon
2691
Dolby
DLB
$5.72B
$98K ﹤0.01%
1,171
-54
-4% -$4.51K
CCRD
2692
DELISTED
CoreCard
CCRD
$97.7K ﹤0.01%
+3,852
New +$99.4K
ELAN icon
2693
Elanco Animal Health
ELAN
$11.3B
$97.6K ﹤0.01%
9,704
+482
+5% +$4.47K
NATR icon
2694
Nature's Sunshine
NATR
$277M
$97.4K ﹤0.01%
7,135
TBCH
2695
Turtle Beach Corp
TBCH
$232M
$97.1K ﹤0.01%
8,339
CVRX icon
2696
CVRx
CVRX
$74.9M
$97.1K ﹤0.01%
+6,289
New +$76.7K
OMF icon
2697
OneMain Financial
OMF
$7.39B
$97K ﹤0.01%
2,221
-156
-7% -$6.09K
LCTX icon
2698
Lineage Cell Therapeutics
LCTX
$273M
$96.9K ﹤0.01%
+68,754
New +$95K
GRNT icon
2699
Granite Ridge Resources
GRNT
$660M
$96.9K ﹤0.01%
+14,615
New +$87.8K
HFFG icon
2700
HF Foods Group
HFFG
$95.4M
$96.7K ﹤0.01%
20,626
+11,172
+118% +$43.7K

Similar funds

MetLife Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.

  • MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
  • MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
  • MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
  • MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
  • MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
  • MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.